MedSpas of America, Inc. (OTC: MEDP), www.medspasofamerica.com operates in a niche sector of the $72 Billion anti-aging market through two distribution channels, those being: (a) Internet retailing; and (b) a small high-end chain of skin care boutiques and medspas to be developed over the next five years. The market is driven, primarily by 44 million female baby boomers who are living longer with unprecedented disposable income and want to look and feel better. 12,000 Americans turn 50 every day (1 every 8 seconds) and this will continue for the next 20 years.
The Company has chosen two entry points into this large and fast growing market, those being: (a) the $5.4 billion cosmeceutical and nutraceutical industry; and (b) the $9.4 billion cosmetic procedures and medical spa market niche, what industry experts are calling “the fastest growing segment of the medical industry.” These two markets have significant synergy as they place the Company on both the services and supply side of one of America’s fastest growing industries. The Company growth goals are achieved through a national branding strategy of its developing skin care products line called Natural Renu and its medical spa brand called Virtuoso Medspa.
Natural Renu
The company has established a new division to penetrate the $5.4 billion cosmeceutical industry under the brand name Natural Renu. The company’s new initiative will be a line of cosmeceutical products focusing on the anti aging and skin healthcare markets. The action reflects the Company's belief in both the strength of the market and the strength of its brand positioning as a key service provider in the markets niches of Plastic Surgeons and Dermatology practices, medical spa’s and day spa’s.
The new division will operate under the brand name of Natural Renu. The company will focus its sales efforts primarily through two marketing channels. The first and primary sales channel shall be Internet Retailing. By utilizing its existing skill set and marketing prowess in this area, the company shall initiate an intensive online awareness campaign and drive potential users of this type of product to its web site. The second target audience shall be to exclusive Plastic Surgeons and Dermatology practices, Day spas, Resorts and Medspas around the world.
According to, Nutrition Science News, the term "cosmeceuticals" was coined after numerous products emerged on the market that combined common cosmetic preparations with nutraceuticals. Cosmeceutical ingredients are most often used in products for anti-aging purposes. US cosmeceuticals demand will grow 8.5 percent annually, propelled by a stream of new products offering age-defying and other appearance-enhancing benefits. Skin care products will remain dominant while professional products will grow the fastest.
Zymetech
The company has entered into a worldwide agreement with Zymetech, Inc. from Reykjavick, Iceland, www.zymetech.com, for the use of Penzyme as the essential ingredient in the anti-aging line of products for Natural Renu.
Under the trademark of Penzim, Zymetech owns the worldwide patents for an active ingredient called Penzyme derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, acne and other skin conditions, such as itching, dry skin and brown spots.
2008 Psychologies Skin Care Survey Results
Zymetech's age management marine enzyme called Penzyme, the main ingredient in its Natural Renu anti-aging cream, was chosen in the March 2008 issue of Psychologies as best for skin refining.
A survey of 200 readers of Psychologies, a U.K. women's magazine, conducted a trial of 100 anti-aging creams selected from categories across the market, is one of the first to blind-test every product involved. Anti-aging products, such as Ponds, Lancome and Skinceuticals, were among the tested products. According to a Psychologies representative, "Packaging shape, logos and branding were completely obscure to provide a uniquely unbiased platform for reader responses."
Links:
Virtuoso Medspa
In the medspa operational niche, the company is developing a national medspa chain under the brand name of Virtuoso MedSpas. Virtuoso was founded by leading practitioners and accomplished executives in response to the growing marketplace demand for technology-based medical spa facilities. The standard Virtuoso medical spa model consists of a 2,000 square foot leased facility located in a high-end, retail shopping environment. Virtuoso offers non-invasive cosmetic skin-care procedures in a spa setting and supervised by medical practitioners. The Company’s expansion plans are to acquire existing medical spas that are strategically located and convert those medical spas to the Virtuoso brand.
Solana Medspas Joint Venture
The company signed a Joint Venture Development Agreement with Solana MedSpas of Irvine, California, in 2006. Under the terms of the MedSpa Development Joint Venture, Solana MedSpas has agreed to provide development services, operational oversight and access to their management team for the company with the intent to build a company owned chain of Medical Spas, under the brand name of Virtuoso Medical Spas. The services provided by Solana will include site selection and build-out of new MedSpas, design services, equipment and supplies procurement, medical protocol and operating systems, recruitment and training of MedSpa staffing, medical regulatory compliance, and marketing programs.
 |
Medspas Aquisition Strategy Aims to Enhance Shareholder Value Through Physical Presence and Diversification of Revenue Streams ATLANTA, GA--(Marketwire - July 31, 2008) - Medspas of America, Inc. (PINKSHEETS: MEDP) -- U.S. Market Penetration is imperative to Medspas overall success and we've made significant progress on this front. Our approach has been centered on evaluating multiple merger and acquisition targets by identifying specific fiscal risk factors which include the following criteria: Quantify liabilities, assess historical performance, determine the competitive advantage, and most importantly in selecting the correct demographic locations. "We are confident in our completed assessments and are moving forward to finalizing agreements with several candidates," stated CEO Paul Smith. (read more) Medspas Approves Launch of Stock Repurchase Program and Votes No on the Utilization of a 504-D Offering ATLANTA, GA--(Marketwire - July 22, 2008) - Medspas of America, Inc. (PINKSHEETS: MEDP), an emerging conglomerate in the flourishing Health and Cosmeceutical industry, has approved the launch of a repurchase shares program of its common stock via open market purchases throughout fiscal 2008 as the Company deems appropriate. Our intention is to continuously enhance shareholder value through the buyback program by reducing the number of shares held by the public with each opportunistic acquisition of our highly undervalued security. "We find no better investment for our leftover retained profits than our own company," stated CEO Paul Smith. (read more) Medspas Reports Positive Clinical Test Results on the Versatile Penzyme Healing Enzyme ATLANTA, GA--(Marketwire - July 14, 2008) - Medspas of America Inc. (PINKSHEETS: MEDP), www.medspasofamerica.com. Two important clinical tests and nine additional clinical observations have been completed on Penzyme, leading to extremely favorable results and excellent news for Medspas. Penzim is the active and main ingredient in its Natural Renu anti-aging cream and gel. Penzyme is truly an amazing product which utilizes purified enzymes that have a deep-healing effect on the body when applied. The versatility for uses of Penzyme provides Medspas with a giant global platform to market and distribute Natural Renu. Penzyme was found to accelerate the healing time for inflammation and pain for osteoarthritis, tendonitis, tendosynovitis, fibromyalgia, muscle aches, trigger points, rheumatoid arthritis, lymphagitis, varicose veins, phlebitis and also helps to reduce pain of UV Radiation burns and wound-healing of pressure sores. (read more) Essential Ingredient in Natural Renu Chosen "Best for Skin Refining" A survey of 200 readers of Psychologies, a U.K. women's magazine, conducted a trial of 100 anti-aging creams selected from categories across the market, is one of the first to blind-test every product involved. Anti-aging products, such as Ponds, Lancome and Skinceuticals, were among the tested products. According to a Psychologies representative, "Packaging shape, logos and branding were completely obscure to provide a uniquely unbiased platform for reader responses." (read more) MedSpas of America Updates Supply Agreement for the Use of Penzim as Ingredient in Natural Renu Under the trademark of Penzim, Zymetech owns the worldwide patents for an active ingredient called Penzyme derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, acne and other skin conditions, such as itching, dry skin and brown spots. (read more)
|